Laekna Therapeutics $61 million Series D financing
We are advising Laekna Therapeutics in connection with its Series D financing
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Deutsche Bank $500 million notes offering
The fixed-rate senior debt funding notes are due 2025
Financials Acquisition £150 million IPO
The shares are listed on the London Stock Exchange
CIFI Holdings (Group) HK$1.957 billion guaranteed convertible bond offering
The guaranteed convertible bonds are due 2025
KKR $750 million senior notes offering
The investment-grade notes are due 2032
Beike’s dual primary listing on the Hong Kong Stock Exchange
This is the first dual primary listing by way of introduction with WVR structure on the HKEX
Philip Morris $17 billion bridge facility for Swedish Match acquisition
We are advising the borrower on the new bridge facility
NXP $1.5 billion senior notes offering
The investment-grade offering includes $1 billion of green bonds
Investcorp India Acquisition $258.8 million IPO
The SPAC offering consists of 25,875,000 units
Bansk Group majority investment in amika and Eva NYC
We advised Bansk Group in the transaction